Instructions on How to Receive Credit
- Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
- Complete the entire activity, pre/post-test and evaluation.
- After passing the post-test, print out your electronic CE certificate.
- In order to successfully complete this activity learners must achieve a minimum of 70% on the post-test.
This activity is supported by an educational grant from Allergan.
This activity is sponsored by the Institute for Continuing Healthcare Education.
Release Date: September 3, 2013
Expiration Date: September 3, 2014
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity. Optometrists
This course is COPE-qualified for 1.0 hour of CE credit. Please check with your state licensing board to see if this approval counts towards your actual CE requirements for relicensure. (COPE-ID #38587-SD)
It is the policy of the Institute to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All persons in control of content must disclose any significant financial interest or other relationships that may affect the content of this activity.
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
Mark T. Dunbar, OD
Bascom Palmer Eye Institute
University of Miami, Miller School of Medicine
Dr. Dunbar has disclosed the following relevant financial relationships that have occured in the last 12 months: Carl Zeiss, Allergan, Artic Dx, Sucampo, Reed Exhibitions/A, PE, G, Carl Zeiss, Allergan, Artic Dx, Sucampo/SB
Mark Bloomenstein, OD
Schwartz Laser Eye Center
Dr. Bloomenstein has disclosed the following relevant financial relationships that have occured in the last 12 months: Allergan, B&L, AMO, TearLab/A, Allergan, B&L, AMO/PE, Allergan/G, Odysset, Allergan, B&L, TearLab, Alcon/SB
Kelly Nichols, OD, MPH, PhD, FAAO
University of Houston, College of Optometry
Dr. Nichols has disclosed the following relevant financial relationships that have occured in the last 12 months: Allergan, Alcon, B&L/PE, Allergan, Alcon, B&L, Sarcode, Nicox, RPS, TearLab/C, Allergan, NIH, TearLab, Alcon/CIBA, Vistakon/G, Sarcode, TearLab/SS
Stephen C. Pfugfelder, MD
Cullen Eye Institute
Department of Ophthalmology
Baylor College of Medicine
Dr. Pflugfelder has disclosed the following relevant financial relationships that have occured in the last 12 months: Allergan, GSK, Bausch and Lomb, Inc./C, Allergan, GSK/G
Neda Shamie, MD
Doheny Eye Institute
Beverly Hills, California
Dr. Shamie has disclosed the following relevant financial relationships that have occured in the last 12 months: B&L, Nicox/C, Allergan, Alcon, B&L, Merck/SB
Clark Springs, MD
Glick Eye Institute
Indiana University, School of Medicine
Dr. Springs has disclosed the following relevant financial relationships that have occured in the last 12 months: Santen, Tear Science/A, R-Tech, Veno/G, Merck, Alcon/H
Donald Editorial Services, LLP
Woodstown, New Jersey
Mr. Donald has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Mark Schaeffer, OD
Schaeffer Eye Center
Dr. Schaeffer has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity. Activity Development and Management Team Cathy Pagano, CCMEP
; Allison A. Muller, Pharm.D, D.ABAT
; Scott Kober, MBA, CCMEP
; April Reynolds, MS, ELS
; Sandra Davidson
; and Megan Small
are employees of the Institute for Continuing Healthcare Education (the Institute) and have no relationships to disclose.
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 18.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
Safari 4.0+ for Mac OSX 10.5 and above
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
For additional technical support, please send an email to email@example.com.
General Disclosure and Copyright Statement
The opinions expressed in this publication are those of the participating faculty and not those of the the Institute, Allergan, or any manufacturers of products mentioned herein.
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.
Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.
Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.